Cellular and molecular mechanisms of metformin: an overview
Open accessThe DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Abstract
Considerable efforts have been made since the 1950s to better understand the cellular and molecular mechanisms of action of metformin, a potent antihyperglycaemic agent now recommended as the first-line oral therapy for T2D (Type 2 diabetes). The main effect of this drug from the biguanide family is to acutely decrease hepatic glucose production, mostly through a mild and transient inhibition of the mitochondrial respiratory chain complex I. In addition, the resulting decrease in hepatic energy status activates AMPK (AMP-activated protein kinase), a cellular metabolic sensor, providing a generally accepted mechanism for the action of metformin on hepatic gluconeogenesis. The demonstration that respiratory chain complex I, but not AMPK, is the primary target of metformin was recently strengthened by showing that the metabolic effect of the drug is preserved in liver-specific AMPK-deficient mice. Beyond its effect on glucose metabolism, metformin has been reported to restore ovarian function in PCOS (polycystic ovary syndrome), reduce fatty liver, and to lower microvascular and macrovascular complications associated with T2D. Its use has also recently been suggested as an adjuvant treatment for cancer or gestational diabetes and for the prevention in pre-diabetic populations. These emerging new therapeutic areas for metformin will be reviewed together with recent findings from pharmacogenetic studies linking genetic variations to drug response, a promising new step towards personalized medicine in the treatment of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In PCOS, metformin reduces insulin resistance and inhibits ovarian androgen production via effects on steroidogenic acute regulatory protein and 17alphahydroxylase (Diamanti-Kandarakis et al. , 2010; Viollet et al. , 2012).”
From Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis (2015) · cites this paper as Viollet et al., 2012
The cited source says what the claim attributes to it.
In the citing paper
“a drug that is currently being used to treat type II diabetic patients, metformin [74], can activate AMPK”
From Senescence of T Lymphocytes: Implications for Enhancing Human Immunity (2016) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“Given the evidence that metformin acts through the mitochondrial electron transport chain (ETC) by inhibiting complex I(46, 210–212) (Figure 8)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [46]
In the citing paper
“By far the most important mechanism is the reduction in hepatic glucose production that is considered mediated by the activation of the global energy sensor in cells, adenosine monophosphate-activated protein kinase (AMPK) (Figure 1).(46)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 4×
“Thus, AMPK activation by metformin induces the phosphorylation and inactivation of acetyl CoA carboxylase (ACC), an important rate-controlling enzyme for the synthesis of malonylCoA, which is both a critical precursor for the biosynthesis of fatty acids and a potent inhibitor of mitochondrial fatty acid oxidation [17].”
BackgroundInfluentialHyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“Furthermore, the authors found a doseresponse relationship between duration of exposure to metformin and cancer incidence [106].”
BackgroundGiovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin
Shaw, R. J., Lamia, K. A., Vasquez, D., Koo, S.-H., Bardeesy, N., DePinho, R. A., Montminy, M., & Cantley, L. C. (2005) · Science · doi:10.1126/science.1120781 · Cited by 1,950 · cited 25×
“Metformin most likely does not directly activate either LKB1 or AMPK as the drug does not influence the phosphorylation of AMPK by LKB1 in cell-free assay [21].”
BackgroundInfluential
Cited by
Items 301–400 of 1,001
Pharmacogenetic studies update in type 2 diabetes mellitus
Singh, S. T., Usman, K., & Banerjee, M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i15.302 · Cited by 77
Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency
Chang, M., Ma, T., Hung, C., Tian, Y., Chen, Y., Yang, C.-W., & Cheng, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-07300-x · Cited by 71
The Role of Hyperglycemia in Endometrial Cancer Pathogenesis
Byrne, F. L., Martin, A. R., Kosasih, M., Caruana, B. T., & Farrell, R. (2020) · Cancers · doi:10.3390/cancers12051191 · Cited by 70
Li, Y., Tan, Y., Xia, G., & Shuai, J. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1951155 · Cited by 63
Cardiovascular impact of drugs used in the treatment of diabetes
Triggle, C. R., & Ding, H. (2014) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622314546125 · Cited by 67
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation
Fusco, D. D., Dinallo, V., Monteleone, I., Laudisi, F., Marafini, I., Franzè, E., Grazia, A. D., Dwairi, R., Colantoni, A., Ortenzi, A., et al. (2018) · Clinical Science · doi:10.1042/cs20180167 · Cited by 71
Schulte, L., Scheiner, B., Voigtländer, T., Koch, S., Schweitzer, N., Marhenke, S., Ivanyi, P., Manns, M. P., Rodt, T., Hinrichs, J. B., et al. (2019) · Liver International · doi:10.1111/liv.14048 · Cited by 67
Li, D. ‐., Huang, F., Lu, W. ‐., Jiang, G. ‐., Deng, Y. ‐., & Shen, F. ‐. (2015) · Acta Physiologica · doi:10.1111/apha.12421 · Cited by 62
Shao, R., Li, X., Feng, Y., Lin, J.-F., & Billig, H. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-41 · Cited by 71
Harada, K., Ferdous, T., Harada, T., & Ueyama, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3523 · Cited by 70
Kim, H. J., Lee, S., Chun, K. H., Jeon, J. Y., Han, S. J., Kim, D. J., Kim, Y. S., Woo, J.-T., Nam, M.-S., Baik, S. H., et al. (2018) · Medicine · doi:10.1097/md.0000000000010036 · Cited by 62
Glucose and Blood Pressure-Dependent Pathways–The Progression of Diabetic Kidney Disease
Patel, D. M., Bose, M., & Cooper, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062218 · Cited by 70
An Update on the Molecular and Cellular Basis of Pharmacotherapy in Type 2 Diabetes Mellitus
Mahgoub, M., Ali, I. I., Adeghate, J. O., Tekes, K., Kalász, H., & Adeghate, E. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119328 · Cited by 74
Sottero, B., Gargiulo, S., Russo, I., Barale, C., Poli, G., & Cavalot, F. L. (2015) · Medicinal Research Reviews · doi:10.1002/med.21349 · Cited by 83
Park, I.-J., Yang, W. K., Nam, S., Hong, J., Yang, K. R., Kim, J., Kim, S. S., Choe, W., Kang, I., & Ha, J. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0929-0 · Cited by 69
Evidence for altered insulin receptor signaling in Alzheimer's disease
Griffith, C. M., Eid, T., Rose, G. M., & Patrylo, P. R. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.008 · Cited by 61
Jia, Y., Lao, Y., Zhu, H., Li, N., & Leung, S.-W. (2018) · Obesity Reviews · doi:10.1111/obr.12753 · Cited by 67
Rodrigues, L., Cravo, P., & Viveiros, M. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1760845 · Cited by 71
Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease
Zhao, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03031-9 · Cited by 66
Ochoa-González, F. D. L., Cervantes-Villagrana, A. R., Fernández-Ruiz, J. C., Nava-Ramirez, H. S., Hernandez-Correa, A. C., Enciso‐Moreno, J. A., & Castañeda‐Delgado, J. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150900 · Cited by 70
Therapeutic Implications of Autophagy Inducers in Immunological Disorders, Infection, and Cancer
Byun, S., Lee, E., & Lee, K. W. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091959 · Cited by 70
Relationships Between Ion Channels, Mitochondrial Functions and Inflammation in Human Aging
Strickland, M., Yacoubi‐Loueslati, B., Bouhaouala‐Zahar, B., Pender, S. L. F., & Larbi, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00158 · Cited by 68
Metformin as an adjuvant in breast cancer treatment
Roshan, M. H. K., Shing, Y. K., & Pace, N. P. (2019) · SAGE Open Medicine · doi:10.1177/2050312119865114 · Cited by 66
Metformin inhibits ROS production by human M2 macrophages via the activation of AMPK
Nassif, R. M., Chalhoub, E., Chedid, P., Hurtado-Nedelec, M., Raya, E., Dang, P. M.-C., Marie, J.-C., & El-Benna, J. (2022) · Biomedicines · doi:10.3390/biomedicines10020319 · Cited by 63
“The transient reduction in cellular energy (a decrease in ATP levels versus an increase in AMP levels), as well as the phosphorylation of AMPK both activate switching of the cell’s status from anabolic to catabolic [1,14,15].”
BackgroundMetformin versus insulin for gestational diabetes mellitus: a meta-analysis
Zhao, L., Sheng, X., Zhou, S., Yang, T., Ma, L., Zhou, Y., & Cui, Y. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12672 · Cited by 63
Chien, H.-C., Zur, A. A., Maurer, T. S., Yee, S. W., Tolsma, J., Jasper, P., Scott, D. O., & Giacomini, K. M. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.066647 · Cited by 63
“Furthermore, mitochondrial respiratory chain complex I is the primary target of metformin (Viollet et al., 2012).”
BackgroundAlzoubi, K., Khabour, O., Al-azzam, S., Tashtoush, M., & Mhaidat, N. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120223201 · Cited by 63
Quintão, F. J. O., Freitas, J. R. L. E., Machado, C. F., de Aquino, S. F., Silva, S. D. Q., & Afonso, R. J. D. C. F. (2016) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.7724 · Cited by 63
Therapeutic application of GPR119 ligands in metabolic disorders
Yang, J. W., Kim, H. S., Choi, Y., Kim, Y., & Kang, K. W. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13062 · Cited by 65
Wastewater analysis reveals spatial pattern in consumption of anti-diabetes drug metformin in China
Yan, J.-H., Yang, X., Tan, D., Shao, X., Wang, Z., & Wang, D. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.01.151 · Cited by 63
Abdolahinia, E. D., Nadri, S., Rahbarghazi, R., Barar, J., Aghanejad, A., & Omidi, Y. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116545 · Cited by 64
Metformin Alters Locomotor and Cognitive Function and Brain Metabolism in Normoglycemic Mice
Li, W., Chaudhari, K., Shetty, R. A., Winters, A., Gao, X., Hu, Z., Ge, W., Sumien, N., Forster, M. J., Liu, R., et al. (2019) · Aging and Disease · doi:10.14336/ad.2019.0120 · Cited by 66
Najar, M. A., Balaya, R. D. A., Modi, P. K., Agarwal, N., Dagamajalu, S., Karthikkeyan, G., Vijayakumar, M., Chatterjee, A., Sankar, U., & Prasad, T. S. K. (2020) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-020-00592-1 · Cited by 68
Yan, X., Zhang, Y., Peng, Y., & Li, X. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115238 · Cited by 64
Moon, H. S., Kim, B., Gwak, H., Suh, D. H., & Song, Y. S. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22284 · Cited by 67
Metformin Therapy in Diabetes: The Role of Cardioprotection
Messaoudi, S. E., Rongen, G. A. P. J. M., & Riksen, N. P. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0314-z · Cited by 66
Metformin-clinical pharmacology in PCOs.
Dumitrescu, R., Mehedințu, C., Briceag, I., Purcărea, V. L., & Hudita, D. (2015) · PubMed Central · Cited by 82
Marini, C., Bianchi, G., Buschiazzo, A., Ravera, S., Martella, R., Bottoni, G., Petretto, A., Emionite, L., Monteverde, E., Capitanio, S., et al. (2016) · Scientific Reports · doi:10.1038/srep19569 · Cited by 64
Spagnolo, P., Kreuter, M., Maher, T. M., Wuyts, W., Bonella, F., Corte, T. J., Kopf, S., Weycker, D., Kirchgaessler, K.-U., & Ryerson, C. J. (2018) · Respiration · doi:10.1159/000489668 · Cited by 61
Metformin-containing hydrogel scaffold to augment CAR-T therapy against post-surgical solid tumors
Chao, Y., Wei, T., Li, Q., Liu, B., Hao, Y., Chen, M., Wu, Y., Song, F., Chen, Q., & Liu, Z. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122052 · Cited by 62
Effects of metformin on energy intake and satiety in obese children
Adeyemo, M. A., McDuffie, J. R., Kozlosky, M., Krakoff, J., Calis, K. A., Brady, S. M., & Yanovski, J. A. (2015) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12426 · Cited by 61
Metformin associated lactic acidosis (MALA): clinical profiling and management
Moioli, A., Maresca, B., Manzione, A., Napoletano, A., Coclite, D., Pirozzi, N., Punzo, G., & Mené, P. (2016) · Journal of Nephrology · doi:10.1007/s40620-016-0267-8 · Cited by 67
Impact of Metformin Use on Lactate Kinetics in Patients with Severe Sepsis and Septic Shock
Park, J., Hwang, S. Y., Jo, I. J., Jeon, K., Suh, G. Y., Lee, T. R., Yoon, H. J., Cha, W. C., Sim, M. S., Carriere, K. C., et al. (2016) · Shock · doi:10.1097/shk.0000000000000782 · Cited by 61
Ghasemnejad‐Berenji, M., Ghazi‐Khansari, M., Yazdani, I., Nobakht, M., Abdollahi, M. R., Ghasemnejad‐Berenji, H., Ansari, J. M., Pashapour, S., & Dehpour, A. R. (2017) · Andrologia · doi:10.1111/and.12846 · Cited by 67
Immunometabolic Pathways and Its Therapeutic Implication in Autoimmune Diseases
Wang, T., Jiao, Y., & Zhang, X. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-020-08821-6 · Cited by 69
Soraya, H., Clanachan, A. S., Rameshrad, M., Maleki‐Dizaji, N., Ghazi‐Khansari, M., & Garjani, A. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.05.003 · Cited by 62
de Oliveira, A. G., & Gomes‐Marcondes, M. C. C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2424-9 · Cited by 61
Tang, Y.-L., Zhu, L.-Y., Li, Y., Yu, J., Wang, J., Zeng, X.-X., Hu, K.-X., Liu, J.-Y., & Xu, J.-X. (2017) · BioMed Research International · doi:10.1155/2017/5905384 · Cited by 57
Hepatoprotective activity of metformin: A new mission for an old drug?
Iranshahy, M., Rezaee, R., & Karimi, G. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.004 · Cited by 63
Hu, Y., Wang, W.-R., Ma, W., Wang, W., Ren, W., Wang, S., Fu, F., & Li, Y. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5475 · Cited by 68
Nurani, M., Akbari, V., & Taheri, A. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.02.067 · Cited by 60
Liu, J., Li, J., Chen, H., Wang, R., Li, P., Miao, Y., & Liu, P. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15241 · Cited by 59
Roy, S., Ghosh, A., Majie, A., Karmakar, V., Das, S., Dinda, S. C., Bose, A., & Gorain, B. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155638 · Cited by 64
Kuo, Y., Lin, C., & Shih, C. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b00073 · Cited by 58
Rajas, F., Labrune, P., & Mithieux, G. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.03.002 · Cited by 60
Wu, C., Shieh, J., Shen, J., Liu, Y.-Y., Chang, Y.-T., & Chen, Y. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2014.08.042 · Cited by 59
McCarthy, A. D., Cortizo, A. M., & Sedlinsky, C. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i6.122 · Cited by 63
Santamaria, A., Alibrandi, A., Benedetto, A. D., Pintaudi, B., Corrado, F., Facchinetti, F., & D’Anna, R. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.05.018 · Cited by 60
Varghese, S., Samuel, S. M., Varghese, E., Kubatka, P., & Büsselberg, D. (2019) · Biomolecules · doi:10.3390/biom9010016 · Cited by 63
Koss‐Mikołajczyk, I., Todorović, V., Sobajic, S. S., Mahajna, J. A., Gerić, M., Tur, J. A., & Bartoszek, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810037 · Cited by 64
Yu, H., Sun, T., He, X., Wang, Z., Zhao, K., An, J., Wen, L., Li, J., Li, W., & Feng, J. (2022) · Aging and Disease · doi:10.14336/ad.2022.0325 · Cited by 57
Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells
Xun, Y. ‐., Zhang, Y. ‐., Pan, Q. ‐., Mao, R., Qin, Y., Liu, H., Zhang, Y., Yu, Y., Tang, Z. ‐., Lu, M., et al. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12187 · Cited by 60
Boyda, H. N., Procyshyn, R. M., Tse, L., Hawkes, E., Jin, C. H., Pang, C. C. Y., Honer, W. G., & Barr, A. M. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110140 · Cited by 55
Sharma, D., Ojha, H., Pathak, M., Singh, B. M., Sharma, N., Singh, A., Kakkar, R., & Sharma, R. K. (2016) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2016.04.030 · Cited by 59
Choi, S. W., & Ho, C. K. (2018) · Redox Report · doi:10.1080/13510002.2017.1324381 · Cited by 57
Metformin, an Anti-diabetic Drug to Target Leukemia
Biondani, G., & Peyron, J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00446 · Cited by 61
New Targeted Treatments for Fragile X Syndrome
Protic, D. D., Salcedo‐Arellano, M. J., Dy, J. B. S., Potter, L. A., & Hagerman, R. J. (2019) · Current Pediatric Reviews · doi:10.2174/1573396315666190625110748 · Cited by 60
Impact of Metformin on Exercise-Induced Metabolic Adaptations to Lower Type 2 Diabetes Risk
Malin, S. K., & Braun, B. (2016) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000070 · Cited by 56
Cincione, R. I., Graziadio, C., Marino, F., Vetrani, C., Losavio, F., Savastano, S., Colao, A., & Laudisio, D. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01943-y · Cited by 63
Berkel, Ç. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01643-3 · Cited by 56
Kim, D., Lee, J. E., Jung, Y. J., Lee, A. S., Lee, S., Park, S. K., Kim, S. H., Park, B., Kim, W. B., & Kang, K. P. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1508 · Cited by 59
Zhu, W., Feng, P.-P., He, K., Li, S.-W., & Gong, J.-P. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.09.134 · Cited by 55
Zhang, R., Liang, Q., Kang, W., & Ge, S. (2019) · Cell Biology International · doi:10.1002/cbin.11202 · Cited by 59
Loos, J. A., & Cumino, A. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126009 · Cited by 56
Metformin overdose-induced hypoglycemia in the absence of other antidiabetic drugs
Abri, S. A. A., Hayashi, S., Thoren, K. L., & Olson, K. R. (2013) · Clinical Toxicology · doi:10.3109/15563650.2013.784774 · Cited by 65
Mitochondrial dynamics: biology and therapy in lung cancer
Lennon, F. E., & Salgia, R. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.899350 · Cited by 55
Teng, R., Du, J., Afolayan, A. J., Eis, A., Shi, Y., & Konduri, G. G. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00200.2012 · Cited by 55
Steen, N. V. D., Caparello, C., Rolfo, C. D., Pauwels, P., Peters, G. J., & Giovannetti, E. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s97644 · Cited by 59
Zhou, Y., Cao, Z., Wang, H., Cheng, Y., Yu, L., Zhang, X.-K., Sun, Y., & Guo, X. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600966 · Cited by 56
Metformin Attenuates Radiation-Induced Pulmonary Fibrosis in a Murine Model
Wang, J., Wang, Y., Han, J., Mei, H., Yu, D., Ding, Q., Zhang, T., Wu, G., Peng, G., & Lin, Z. (2017) · Radiation Research · doi:10.1667/rr14708.1 · Cited by 58
Mantuano, P., Sanarica, F., Conte, E., Morgese, M. G., Capogrosso, R. F., Cozzoli, A., Fonzino, A., Quaranta, A., Rolland, J., Bellis, M. D., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.04.022 · Cited by 56
Li, G., Zhao, S., Cui, S., Li, L., Xu, Y., & Li, Y. (2015) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3566-0 · Cited by 54
Zamanian, M. Y., Golmohammadi, M., Yumashev, A., Hjazi, A. M., Toama, M. A., AbdRabou, M. A., Gehlot, A., Alwaily, E. R., Shirsalimi, N., Yadav, P. K., et al. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4071 · Cited by 60
Buler, M., Aatsinki, S.-M., Izzi, V., & Hakkola, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049863 · Cited by 52
Pradeep, A. R., Patnaik, K., Nagpal, K., Karvekar, S., Ramamurthy, B. L., Naik, S. B., Suke, D. K., Singh, P., & Raju, A. P. (2015) · Journal of Investigative and Clinical Dentistry · doi:10.1111/jicd.12150 · Cited by 57
Thomas, A. P., Hoang, J. D., Vongbunyong, K. E., Nguyen, A., Rakshit, K., & Matveyenko, A. V. (2016) · Endocrinology · doi:10.1210/en.2016-1309 · Cited by 60
Associations between Diabetes Mellitus and Selected Cancers
Pliszka, M., & Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137476 · Cited by 61
Wan, X., Huo, Y., Johns, M., Piper, E., Mason, J. C., Carling, D., Haskard, D. O., & Boyle, J. J. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.300986 · Cited by 57
Sahu, B. D., Kuncha, M., Putcha, U. K., & Sistla, R. (2013) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2013.01.007 · Cited by 53
Ljubicic, V., & Jasmin, B. J. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.07.002 · Cited by 58
The effect of immunosuppressive molecules on T-cell metabolic reprogramming
Fernández-Ramos, A. A., Poindessous, V., Marchetti, C., Pallet, N., & Loriot, M. (2016) · Biochimie · doi:10.1016/j.biochi.2016.04.016 · Cited by 54
Schexnayder, C., Broussard, K., Onuaguluchi, D., Poché, A., Ismail, M., McAtee, L., Llopis, S. D., Keizerweerd, A., McFerrin, H. E., & Williams, C. C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113692 · Cited by 53
Overview of Metformin and Neurodegeneration: A Comprehensive Review
Kruczkowska, W., Gałęziewska, J., Buczek, P., Płuciennik, E., Kciuk, M., & Śliwińska, A. (2025) · Pharmaceuticals · doi:10.3390/ph18040486 · Cited by 58
Gong, Z., Aragaki, A. K., Chlebowski, R. T., Manson, J. E., Rohan, T. E., Chen, C., Vitolins, M. Z., Tinker, L. F., LeBlanc, E. S., Kuller, L. H., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.29944 · Cited by 50
Madsen, A., Bozickovic, O., Bjune, J.-I., Mellgren, G., & Sagen, J. V. (2015) · Scientific Reports · doi:10.1038/srep16430 · Cited by 52
Genomic Characterization of Metformin Hepatic Response
Luizon, M. R., Eckalbar, W. L., Wang, Y., Jones, S. L., Smith, R. P., Megan, L., Lin, L., Gallins, P. J., Etheridge, A. S., Wright, F. A., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006449 · Cited by 53
Yeh, H., Ting, I., Tsai, C.-W., Wu, J., & Kuo, C. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0640-4 · Cited by 57
Population and allelic variation of A-to-I RNA editing in human transcriptomes
Park, E., Guo, J., Shen, S., Demirdjian, L., Wu, Y. N., Lin, L., & Xing, Y. (2017) · Genome biology · doi:10.1186/s13059-017-1270-7 · Cited by 71
Metformin: A Possible Option in Cancer Chemotherapy
Ugwueze, C. V., Ogamba, O. J., Young, E. E., Onyenekwe, B. M., & Ezeokpo, B. C. (2020) · Analytical Cellular Pathology · doi:10.1155/2020/7180923 · Cited by 54
Biological Properties of Transition Metal Complexes with Metformin and Its Analogues
Rusanov, D. A., Zou, J., & Babak, M. V. (2022) · Pharmaceuticals · doi:10.3390/ph15040453 · Cited by 57
Metadata
- Authors
- Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F.
- Affiliations
- INSERM, U1016, Institut Cochin, Paris, France
- Leiden University Medical Center (NL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Leclerc, Jocelyne
- Foretz, Marc
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2011-11-11
- Volume
- 122
- Issue
- 6
- Pages
- 253-270
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- PMC
- PMC3398862
- OpenAlex
- W2154024784
- Cited by
- 1,720
- References
- 167
- Citations by year
- 2026: 63 · 2025: 85 · 2024: 96 · 2023: 103 · 2022: 106 · 2021: 143 · 2020: 155 · 2019: 135 · 2018: 141 · 2017: 156 · 2016: 137 · 2015: 144 · 2014: 117 · 2013: 104 · 2012: 34
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- HAL (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Keywords
- metformin, type 2 diabetes, biguanides, AMPK, mitochondrial complex I inhibition, hepatic gluconeogenesis, hepatic glucose production, polycystic ovary syndrome, hepatic steatosis, diabetes complications, adjuvant cancer therapy, gestational diabetes mellitus, prediabetes, pharmacogenetics, personalized medicine
- MeSH terms
- Animals, Cardiovascular System, Diabetic Nephropathies, Female, Humans, Hypoglycemic Agents, Metformin, Neoplasms, Polycystic Ovary Syndrome, Circadian Clocks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.